// App-Quantinova.ai

TCT-562 : Sex Differences in Ticagrelor With or Without Aspirin After Percutaneous Coronary Interventions in Acute Coronary Syndrome Patients: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial

Researchers

Presenter

  • Jong-Il Park

Principal Investigators

  • Bom Lee

  • Seung-Jun Lee

  • Yong-Joon Lee

  • Sung-Jin Hong

  • Chul-Min Ahn

  • Jung-Sun Kim

  • Young-Guk Ko

  • Donghoon Choi

  • Myeong-Ki Hong

  • Byeong-Keuk Kim

Medical Centers

  • Severance Hospital, Seoul, Republic of Korea

  • Yonsei University College of Medicine, Seoul, Republic of Korea

  • Division of Cardiology, Severance Hospital, Yonsei University, Seoul, Republic of Korea

  • YUHS, Seoul, Republic of Korea

  • Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved